Histology of Visceral and Subcutaneous Fat

Both are “fat” — so what is different? From histology to metabolism and disease

Published

October 13, 2026

Introduction

English version — machine-assisted translation (by generative AI, Anthropic Claude) of the original Japanese hands-on. 日本語版はこちら.

This material is a lecture handout for understanding, step by step, how visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) differ when viewed under the microscope, and why those differences translate into differences in clinical risk.

Abdominal (visceral-type) obesity is known to carry a higher risk of diabetes and cardiovascular disease than gluteal–femoral (peripheral-type) obesity, and the differences between the two span the anatomical, cellular, molecular, physiological and clinical levels (Ibrahim 2010; Wajchenberg 2000). Starting from the image of “fat = just an energy store,” this material builds up, in the order histology → metabolism → pathology, the view that adipose tissue is a single organ containing blood vessels, nerves and immune cells (Cinti 2005), and an organ whose character differs by location (Tchkonia et al. 2013; Lee et al. 2013). Finally, using a model that runs in the browser, you will check hands-on “whether fat cells grow larger or increase in number” and “what happens when subcutaneous fat overflows.”

WarningCaution

This material is for educational purposes. Do not use it for individual diagnostic or treatment decisions; refer to the latest clinical practice guidelines.

  • Wherever possible, statements in the text are given in-text citations. Bibliographic details (authors, journal, volume, pages, DOI) were checked on PubMed, and support for each claim was checked mainly against each paper’s abstract. Some references could not be checked in full-text detail, so please consult the original sources if you cite them in lectures or papers.
  • Because the distribution and properties of adipose tissue differ considerably between humans and mice (rodents), it is stated explicitly which species a finding comes from.
  • Statements without citations are either general textbook knowledge of histology or the author’s own explanations (analogies, the assumptions of the model in Chapter 7, etc.).

Intended audience

  • Students in medicine, pharmacy, nursing, nutrition, life sciences or sports science, and healthcare professionals
  • Readers with physiology/biochemistry knowledge at the level of “insulin lowers blood glucose” and “triglycerides are made from fatty acids and glycerol”

What this lecture aims for

  1. Be able to describe the histology of white adipose tissue (unilocular adipocytes, stromal vascular fraction)
  2. Be able to explain the histological differences between visceral and subcutaneous fat (density of blood vessels and nerves, immune cells, progenitor cells, cell size)
  3. Be able to explain their metabolic differences (propensity for lipolysis, portal vs systemic circulation, secreted adipokines)
  4. Be able to explain differences in fat distribution by sex, age and ethnicity, and their background
  5. Using the adipose tissue expandability hypothesis, be able to explain the sequence “insufficient adipose tissue capacity → increased ectopic fat → metabolic abnormalities”

Chapter structure

Chapter Content Approx. time
1 Distribution and classification of adipose tissue 15 min
2 Histology of white adipose tissue 20 min
3 Visceral vs subcutaneous fat: histological differences 25 min
4 Visceral vs subcutaneous fat: metabolic and endocrine differences 25 min
5 Differences by sex, age and ethnicity 15 min
6 The adipose tissue expandability hypothesis and ectopic fat 20 min
7 Hands-on: running the models in the browser 20 min
8 Review questions 20 min
NoteSlide version

Key-point slides for the lecture are here. Press F for full screen, S for speaker notes, Esc for the overview. The slides also carry citations on each page, with a reference list at the end.

The big picture first

Before going into details, here is a map of the whole lecture (the evidence for each arrow is explained, with citations, in the respective chapter).

flowchart LR
  E["Surplus energy"] --> S["Subcutaneous fat<br/>High progenitor proliferation<br/>and differentiation capacity<br/>(Ch. 3)"]
  S -->|"Capacity limit<br/>(Ch. 6)"| V["Visceral fat<br/>Many vessels, nerves, immune cells<br/>Active lipolysis (Ch. 3, 4)"]
  S -->|"Capacity limit<br/>(Ch. 6)"| X["Ectopic fat<br/>liver, muscle, etc."]
  V -->|"Free fatty acids<br/>via the portal vein<br/>(Ch. 4)"| L["Liver"]
  V --> A["Adiponectin↓<br/>PAI-1↑ etc.<br/>(Ch. 4)"]
  X --> M["Insulin resistance<br/>Metabolic abnormalities"]
  L --> M
  A --> M

Glossary

White adipose tissue (WAT)

Adipose tissue that stores triglycerides. Both visceral and subcutaneous fat are WAT.

Brown adipose tissue (BAT)

Adipose tissue that produces heat via UCP1. PET-CT has shown it is present even in adults, in the neck and supraclavicular regions, etc. (Cypess et al. 2009).

Beige adipocytes

Thermogenic cells that appear within white fat and strongly express UCP1 upon stimulation (Wu et al. 2012).

Unilocular adipocyte

A cell most of whose volume is occupied by a single large lipid droplet; the typical shape of a white adipocyte (Pawlina and Ross 2020).

Stromal vascular fraction (SVF)

What remains of adipose tissue after removing the adipocytes. Includes preadipocytes, vascular endothelium, immune cells, etc.

Hypertrophy / hyperplasia

Hypertrophy is an individual adipocyte getting larger; hyperplasia is an increase in the number of cells (Stenkula and Erlanson-Albertsson 2018).

Ectopic fat

Lipid accumulated in cells/organs that are not normally fat stores (liver, skeletal muscle, etc.) (Virtue and Vidal-Puig 2010).

Adipokines

Collective term for the bioactive substances secreted by adipose tissue: adiponectin, leptin, IL-6, PAI-1, etc.